The rapid development of biotechnology has made microarray technology an important tool in life science research. CapitalBiotech's microarray scanners have become a leader in this field due to their excellent performance and wide range of applications.
Technology Overview
CapitalBiotech's microarray scanner is a compact, high-performance system-an advanced experimental device based on the principle of fluorescence imaging. It excites fluorescein markers in the sample by irradiating them with laser or LED light and uses an optical imaging system to record, calculate, and process the fluorescence intensity at each sample location. This technology can measure the expression levels of thousands to millions of genes, proteins, or other biomolecules simultaneously, providing researchers with a high-throughput, high-sensitivity means of analysis.
Product Features
High Performance
CapitalBiotech's microarray scanner uses advanced signal acquisition and processing technology to provide excellent scanning accuracy and high detection sensitivity over a wide linear dynamic range. This makes it ideal for profiling high-density speckle microarrays.
Flexible Configuration
CapitalBiotech's microarray scanner offers a wide range of models and configuration options to meet different experimental needs. Whether it is single or dual color fluorescence detection, high or low density microarray chips, CapitalBiotech provides the right solution.
Ease of Use
CapitalBiotech's microarray scanner is easy to operate and user-friendly. With an intuitive interface and a concise operating procedure, users can easily complete experimental setup and data acquisition.
Reliability
CapitalBiotech's microarray scanner is highly stable and reliable. It incorporates precise mechanical structure and high-quality optical components to ensure the accuracy and repeatability of experimental results.
Application Areas
CapitalBiotech's microarray scanner has a wide range of applications in bioscience research. It enables researchers to measure the expression levels of thousands to millions of genes simultaneously, which in turn can identify the different expression levels of certain genes under varying conditions. In disease research, CapitalBiotech's microarray scanner can detect differences in gene expression between cancer cells and normal cells, providing new ideas and methods for disease diagnosis and treatment. Additionally, it is applicable to DNA methylation detection, immune disease detection, bacterial identification, drug residue detection and many other fields.
Company Background
As a leading company in the field, CapitalBiotech, with its strong R&D capabilities and extensive product portfolio, provides high-quality biochip products and solutions to researchers worldwide.
As an important tool in biotechnology, CapitalBiotech's microarray scanners have become the right hand of researchers with excellent performance and wide-ranging applications. As biotechnology continues to advance and applications expand, CapitalBiotech's microarray scanners will continue to play an important role in driving bioscience research to new heights.
Knowledge About Transcriptome SequencingDecember 1, 2022In a broad sense, the transcriptome refers to the collection of all transcripts in a cell under a certain physiological condition, including messenger RNA, ribosomal RNA, transfer RNA and non-coding R...view
What Are the Clinical Presentations of Colorectal Cancer?April 4, 2023Colorectal cancer is a common malignant tumor, including colon cancer and rectal cancer. The incidence of colorectal cancer is highest in the rectum, followed by the sigmoid colon, cecum, ascending co...view
Basic Performance of In Vitro Diagnostic Reagent ProductsMarch 9, 20231. Blank IVD in vitro diagnostic reagentsThe reagent blank can be understood as the value detected when the content of the substance to be tested is the theoretical zero value. The general practice is...view